Home / Daily Dose / Diving Into New Mortgage Data Print This Post Nicole Casperson is the Associate Editor of DS News and MReport. She graduated from Texas Tech University where she received her M.A. in Mass Communications and her B.A. in Journalism. Casperson previously worked as a graduate teaching instructor at Texas Tech’s College of Media and Communications. Her thesis will be published by the International Communication Association this fall. To contact Casperson, e-mail: [email protected] On Monday, the Data & Analytics division of Black Knight, Inc. released its latest Mortgage Monitor Report for November 2017.According to the data, as of the end of Q3 2017, 42 million homeowners with a mortgage now have an aggregate of nearly $5.4 trillion in equity available to borrow against.Ben Graboske, EVP of Data & Analytics at Black Knight, said that this represents an all-time high, and up more than $3 trillion since the bottom of the market in 2012—as over 80 percent of all mortgage holders now have available equity to tap via first-lien cash-out refinances or home equity lines of credit (HELOCs).“We’ve noted in the past that as interest rates rise from historic lows, HELOCs represented an increasingly attractive option for these homeowners to access their available equity without relinquishing interest rates below today’s prevailing rate on their first-lien mortgages,” Graboske explained. “However, with the recently passed tax reform package, interest on these lines of credit will no longer be deductible, which increases the post-tax expense of HELOCs for those who itemize.”There are many factors to consider before a borrower determines which method of equity extraction is the most economical, but Graboske noted that in many cases for those with high unpaid principal balances (UPB) who are taking out lower line amounts, the math still favors HELOCs.“However—assuming interest on cash-out refinances remains deductible—for low-to-moderate UPB borrowers taking out larger amounts of equity, the post-tax math for those who will still itemize under the increased standard deduction may now favor cash-out refinances instead, even if the result is a slight increase to first-lien interest rates,” said Graboske.The report also takes an in-depth look at how the increase in equity, driven by rising home prices, has also continued to decrease the population of underwater borrowers.Black Knight’s analysis notes that the number of underwater borrowers declined by 800,000 over the first nine months of 2017—representing a 37 percent decline in negative equity. Only 2.7 percent of homeowners with a mortgage, which is an estimated 1.36 million borrowers, now owe more than their home is worth, which is the lowest rate since 2006.Additionally, Black Knight’s data found that the national delinquency rate jumped by 2.5 percent from last month, attributing the increase to “typical seasonality.” Meanwhile, November experienced the second-fewest foreclosure starts in 2017 and the third fewest of any month since 2004. In addition, prepayment activity dropped by 12.41 percent month-over-month, falling to 31.47 percent below last year’s level.To view the full report, click here. Data Provider Black Knight to Acquire Top of Mind 2 days ago Related Articles Black Knight HOUSING mortgage Mortgage Monitor 2018-01-08 Nicole Casperson in Daily Dose, Featured, Market Studies, News The Best Markets For Residential Property Investors 2 days ago Sign up for DS News Daily Demand Propels Home Prices Upward 2 days ago Data Provider Black Knight to Acquire Top of Mind 2 days ago Share Save Governmental Measures Target Expanded Access to Affordable Housing 2 days ago About Author: Nicole Casperson Diving Into New Mortgage Data Tagged with: Black Knight HOUSING mortgage Mortgage Monitor The Best Markets For Residential Property Investors 2 days ago Demand Propels Home Prices Upward 2 days ago January 8, 2018 2,209 Views Servicers Navigate the Post-Pandemic World 2 days ago Previous: CoreLogic Announces General Counsel Appointment Next: Freddie Mac Expands Credit Risk Transfer Program The Week Ahead: Nearing the Forbearance Exit 2 days ago Governmental Measures Target Expanded Access to Affordable Housing 2 days ago Servicers Navigate the Post-Pandemic World 2 days ago Subscribe
The Harvard Art Museums present two traveling exhibitions devoted to underexplored aspects of the work of Lyonel Feininger (1871–1956), one of the major figures of European modernism. Lyonel Feininger: Drawings and Watercolors from the William S. Lieberman Bequest to the Busch-Reisinger Museum highlights an important recent acquisition of a stunning group of drawings and watercolors from the collection of the legendary curator. Lyonel Feininger: Photographs, 1928–1939, assembled primarily from Harvard University’s Houghton Library, is the first to explore the artist’s little-known photographic work. Drawing on vast but largely untapped resources and new research, the two exhibitions and their accompanying catalogues examine the aesthetic and intellectual dimensions of Feininger’s achievements within each of these distinct media. Many of the works included have never before been exhibited or published and thus allow for a fresh assessment of this otherwise well-known figure.Feininger at Harvard: Drawings, Watercolors, and Photographs, which encompasses both exhibitions, will be presented in Germany at the Kupferstichkabinett, Staatliche Museen zu Berlin from Feb. 25 to May 15, 2011, and the Pinakothek der Moderne, Munich from June 2 to July 17, 2011. Lyonel Feininger: Photographs, 1928–1939 then travels to the J. Paul Getty Museum, Los Angeles, where it will be on view from Oct. 25, 2011 to March 11, 2012. In Los Angeles it will be complemented by a related installation of photographs by Bauhaus masters and students from the Getty’s collection. The final venue for the photography exhibition will be the Harvard Art Museums/Arthur M. Sackler Museum, from March 30 to June 2, 2012, where it will be accompanied by a selection of works from the drawings and watercolors exhibition.
ShareShareSharePrintMailGooglePinterestDiggRedditStumbleuponDeliciousBufferTumblr Visa has rolled out four new security features that alert financial institutions about fraudulent ATM activity and card-not-present fraud, as well as detect security vulnerabilities in EMV transactions and merchant websites.The company said the features would help protect the integrity of the payments ecosystem and would be available to Visa clients at no additional cost.“Cybercriminals attempt to bypass traditional defenses by stealing credentials, harvesting data, obtaining privileged access and attacking trusted third-party supply chains,” Visa Payment System Risk SVP RL Prasad said. “Visa’s new payment security capabilities combine payment and cyber intelligence, insights and learnings from breach investigations, and law enforcement engagement to help financial institutions and merchants solve the most critical security challenges.” continue reading »
Nov 2, 2009 (CIDRAP News) – Interim clinical trial findings announced today affirm that children younger than 10 need two pandemic H1N1 vaccine doses, and initial findings in pregnant women reveal no safety concerns and a need for only one dose.Federal officials also detailed the role of an independent panel of experts to review vaccine safety data and released a report outlining the government’s vaccine safety monitoring system.At a media briefing today, Bruce Gellin, MD, director of the National Vaccine Program at the US Department of Health and Human Services (HHS), said federal officials realize that, despite problems with vaccine supply and demand, Americans still have concerns about its safety. He told reporters that an independent expert group charged with reviewing vaccine safety data met for the first time today to become familiar with the data sources they’ll be reviewing.In addition, a federal task force today released a 20-page report that outlines beefed-up systems that officials have put in place to monitor the safety of the vaccine. US health officials are mindful of the 1976 swine flu vaccination campaign, which reached more than 40 million people but was associated with an increase in cases of Guillian-Barre syndrome, a temporary paralytic condition.Though vaccine safety and purifications steps are much more advanced today, officials have added new systems to track the pandemic H1N1 vaccine and are taking extra steps to add transparency to the process, in hopes of reassuring the public.Anne Schuchat, MD, director of the CDC’s National Center for Immunization and Respiratory Diseases, told reporters that a cumulative total of 30 million doses of pandemic H1N1 vaccine have been produced for states to order, which represents an increase of 3.4 million since Friday.Vaccine data for childrenThe latest findings of vaccine efficacy in children come on the heels of a recommendation from World Health Organization (WHO) vaccine experts who on Oct 30 recommended that most people, even young children, receive just one dose of the vaccine.Though the group acknowledged they didn’t have much data to base their guidance on, they said countries that have placed children as a high-priority group to receive the vaccine should administer one dose so they can immunize as many children as possible.Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, said the findings today, from National Institutes of Health (NIH) studies, are critical to public health officials who are charged with making policy decisions and to the public for making personal decisions for themselves and their loved ones.He said interim results on vaccine in healthy children ages 6 months to 17 years confirm early results reported on Sep 21. The new findings show that children younger than 10 who receive a second 15-microgram (mcg) dose of pandemic H1N1 vaccine have significant immune response improvement.The new data were obtained 8 to 10 days after the second vaccine dose, compared with the first findings, which were obtained 21 days after the first dose.In the youngest children (6 to 35 months), 100% had a robust immune response after the second dose compared with only 25% after the first dose. In those ages 3 through 9, 94% had a robust immune response after the second dose, compared with 55% after the first dose.Immune responses were comparable in those receiving two 15-mcg doses and in those who got two 30-mcg doses, suggesting that the smaller dose is enough to elicit a strong immune response, according to an NIH press release today.”Our guidelines seem to fit quite nicely with the science,” Fauci said at the news conference. “We would like to get children as fully protected as we can.”Efficacy in pregnant womenIn the initial results on the vaccine in pregnant women, immune response to the pandemic H1N1 shot was similar to that seen in healthy adults.Public health officials have placed pregnant women at the front of the line to receive the vaccine because they have been disproportionately hit by the virus. So far the CDC has received reports of at least 100 pandemic flu infections in pregnant women that required intensive care unit (ICU) treatment, as well as reports of 28 deaths.In a subgroup of 50 pregnant women participating in an NIH clinical trial, a preliminary analysis of blood drawn 21 days after vaccination showed the vaccine was likely protective in 23 of 25 women (92%) who received a single 15-mcg dose and that it was likely protective in 24 of 25 (96%) who received a single 30-mcg dose.The trial began on Sep 9, according to an NIH press release. Participants were between ages 18 and 39 and were in their second or third trimester when they began the study. The ongoing study will also assess the effects of a second dose. Investigators are using Sanofi’s pandemic H1N1 vaccine, which does not contain the preservative thimerosal or an immune-response-boosting adjuvant.Despite the heightened threat of the virus to pregnant women, public health officials worry about the uptake of the pandemic vaccine in this group, because only about 15% of pregnant women typically receive the seasonal vaccine. Safety monitoring of the drug conducted by researchers and an independent expert panel so far suggests that the vaccine is well tolerated, with no safety concerns so far.”For pregnant women, who are among the most vulnerable to serious health problems from 2009 H1N1 infection, these initial results are very reassuring,” Fauci said.Vaccine-safety groupGellin said the independent vaccine safety expert group that met today in its first face-to-face meeting will meet biweekly to review the latest data and will report its findings each month in a publicly accessible conference call with the HHS’s National Vaccine Advisory Committee.The vaccine safety group will be receiving regular briefings from the NIH and the Biomedical Advanced Research and Development Agency (BARDA) and can convene rapidly if needed.See also:Nov 2 NIH press release on vaccine response in childrenNov 2 NIH press release on vaccine response in pregnant womenFederal Immunization Task Force report on plans for monitoring pandemic H1N1 vaccine safetySep 21 CIDRAP News story “Trial predicts 2 H1N1 shots for young kids, 1 for older”